Apathy
Apathy is a condition characterized by a lack of interest, enthusiasm, or concern, often seen in individuals with neurological disorders or after a stroke. It can affect motivation and emotional responses.
Apathy After Stroke: Brain Pathway Study
We are examining how cholinergic and dopaminergic systems relate to apathy in stroke patients. This study aims to understand the brain's role in apathy to improve future treatments.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Stroke
A stroke occurs when blood flow to an area of the brain is interrupted, leading to brain damage. Symptoms can vary widely depending on the area affected and may include sudden weakness, confusion, and difficulty speaking.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 18 and 75 years old?
- Do you have any major heart problems, like severe heart failure?
- Are you currently pregnant or breastfeeding?
- Are you taking any medications that affect your brain, like Amitriptyline or Haloperidol?
- Do you have a chronic neurological disorder or severe psychiatric disorder?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Dopacis
Fluoroethoxybenzovesamicol
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Centre Hospitalier Universitaire De Bordeaux
Médecine Nucléaire
Bordeaux, France
Sponsor: Centre Hospitalier Universitaire De Bordeaux
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.